Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 2/20 | 0.46 |
| ▸ | CCR8 | P51685 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | ALPL | P05186 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | ALPI | P09923 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CCR5 | P51681 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29539234 | 1.00 | CCR1 (0.46) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL700152 | 0.97 | CCR1 (0.46) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL31354842 | 0.97 | CCR1 (0.46) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL16705267 | 0.85 | CCR1 (0.36) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL16511928 | 0.85 | CYP3A4 (0.40) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL3419835 | 0.85 | CCR1 (0.73) | CCR1CCR8RAB9ATGFBR1MAPK14 | |
| SCHEMBL23598723 | 0.83 | MEN1 (0.70) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL30485904 | 0.83 | KDM4E (0.71) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL29946428 | 0.83 | KDM4E (0.71) | CCR1CCR8KDM4ELMNATP53 | |
| SCHEMBL353379 | 0.83 | KDM4E (0.71) | CCR1CCR8KDM4ELMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | claimed |
| EP-4473309-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2024-12-11 | — | — | EP | claimed |
| WO-2023196986-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2023-10-12 | — | — | WO | claimed |
| US-20230167144-A1 | PREPARATION AND ITS APPLICATION OF A CYANIDE-BRIDGED METAL ORGANIC COMPOUND WITH INTRAMOLECULAR MAGNETIC TRANSFORMATION | Hubei Jingmen Industrial Technology Research Institute Co., Ltd. (CN) | 2023-06-01 | — | — | US | claimed |
| EP-1119573-A2 | BIPYRIDINE MANGANESE COMPLEXES | EUKARION, INC. (US) | 2001-08-01 | — | — | EP | claimed |
| WO-2000009512-A2 | BIPYRIDINE MANGANESE COMPLEXES | EUKARION, INC. (US) | 2000-02-24 | — | — | WO | claimed |
| CN-116917271-B | Process for producing arylthiol ester compound | ＡＧＣ株式会社 | 2026-05-15 | — | — | CN | disclosed |
| US-20260125402-A1 | Novel Carbonylation Catalysts And Methods Of Making The Same | NOVOMER INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | disclosed |
| US-12459960-B2 | Carbonylation catalysts and methods of making the same | NOVOMER, INC. (US) | 2025-11-04 | — | — | US | disclosed |
| EP-4631621-A2 | NOVEL CARBONYLATION CATALYSTS AND METHODS OF MAKING THE SAME | Novomer, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| EP-4319916-B1 | NOVEL CARBONYLATION CATALYSTS AND METHODS OF MAKING THE SAME | NOVOMER INC (US) | 2025-08-27 | — | — | EP | disclosed |
| EP-4026881-B1 | ORGANIC THIN FILM AND METHOD FOR PRODUCING ORGANIC THIN FILM | JAPAN BROADCASTING CORP (JP) | 2025-07-30 | — | — | EP | disclosed |
| EP-0787719-B1 | CONJUGATED N-FLUOROPYRIDINIUM SALT POLYMER AND USE THEREOF | DAIKIN IND LTD (JP) | 2001-08-16 | — | — | EP | disclosed |
| EP-1119573-A2 | BIPYRIDINE MANGANESE COMPLEXES | EUKARION, INC. (US) | 2001-08-01 | — | — | EP | disclosed |
| US-6177419-B1 | ANTIOXIDANT CHELATE COMPOUNDS FOR PREVENTING OXYGEN FREE RADICAL-ASSOCIATED DISEASES IN MAMMALS; NEUROPROTECTANTS, SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT) AND/OR PEROXIDASE (POD) MIMETICS | EUKARION, INC. | 2001-01-23 | — | — | US | disclosed |
| EP-1006135-A1 | Conjugated N-fluoropyridinium salt-containing polymer and use of the same | DAIKIN INDUSTRIES, LIMITED (JP) | 2000-06-07 | — | — | EP | disclosed |
| WO-2000009512-A2 | BIPYRIDINE MANGANESE COMPLEXES | EUKARION, INC. (US) | 2000-02-24 | — | — | WO | disclosed |
| US-5736274-A | ANODE ACTIVE MATERIAL AND SOLID ELECTROLYTE FOR BATTERIES; HIGH ELECTROMOTIVE FORCE; HIGH ENERGY DENSITY; POLLUTION CONTROL; FLUORINATING AGENTS; LOW INTERNAL RESISTANCE IN CHARGING AND DISCHARGING | DAIKIN INDUSTRIES, LTD. (JP) | 1998-04-07 | — | — | US | disclosed |
| EP-0787719-A1 | CONJUGATED N-FLUOROPYRIDINIUM SALT POLYMER AND USE THEREOF | DAIKIN INDUSTRIES, LTD. (JP) | 1997-08-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125402-A1 | Novel Carbonylation Catalysts And Methods Of Making The Same | CBR1, CBR3, SOD1 | CCR1 369/4885CCR8 1269/4885KDM4E 491/4885 |
| US-12459960-B2 | Carbonylation catalysts and methods of making the same | CBR1, CBR3, DCXR | CCR1 2138/4885CCR8 2408/4885KDM4E 923/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.